Table 1. Correlations between p-ERK and ERK expression and various clinicopathologic parameters in ESCC.
Parameter | Case NO. | low/high expression | ||
---|---|---|---|---|
p-ERK | ERK | |||
Age | ≤ 57 | 66 | 38/28 | 20/46 |
> 58 | 65 | 27/38 | 20/45 | |
Gender | Male | 98 | 48/50 | 31/67 |
Female | 33 | 17/16 | 9/24 | |
Tumor site | Upper | 13 | 4/9 | 3/10 |
Middle | 104 | 54/50 | 33/71 | |
Lower | 14 | 7/7 | 4/10 | |
Differentiation | Poor | 12 | 4/8*0.04 | 2/10*0.012 |
Intermediate | 75 | 37/38 | 20/55 | |
Well | 44 | 30/14 | 18/16 | |
Tumor size | > 5 cm | 82 | 40/42 | 25/57 |
< 5 cm | 49 | 25/24 | 15/34 | |
Depth of invasion | T1–T2 | 103 | 55/48 | 28/75 |
T3–T4 | 28 | 10/18 | 12/16 | |
Lymph metastasis | Yes | 68 | 31/37 | 18/50 |
No | 63 | 34/29 | 22/41 | |
Clinical Stage | 1 | 6 | 4/2*0.02 | 5/1*0.031 |
2 | 55 | 35/20 | 17/38 | |
3 | 64 | 25/39 | 17/47 | |
4 | 6 | 1/5 | 1/5 |
* p < 0.05.